| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS44045428 | HTLV-1 | ENSG00000091831.25 | protein_coding | ESR1 | Yes | No | 2099 | A0A125SXW3 G4XH65 H0Y4W6 P03372 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | ESR1 |
|---|---|
| DrugBank ID | DB13310 |
| Drug Name | Ormeloxifene |
| Target ID | BE0000123 |
| UniProt ID | P03372 |
| Regulation Type | modulator |
| PubMed IDs | 17280556; 28458475 |
| Citations | Awasthi S, Blesson CS, Dwivedi A: Expression of oestrogen receptors alpha and beta during the period of uterine receptivity in rat: effect of ormeloxifene, a selective oestrogen receptor modulator. Acta Physiol (Oxf). 2007 Jan;189(1):47-56. doi: 10.1111/j.1748-1716.2006.01638.x.@@Pati T, Chanania K, Marandi S, Hansa J: Ormeloxifene - Looking beyond contraception. J Midlife Health. 2017 Jan-Mar;8(1):17-20. doi: 10.4103/jmh.JMH_71_16. |
| Groups | Experimental |
| Direct Classification | 7-O-methylated isoflavonoids |
| SMILES | [H][C@@]1(C2=CC=C(OCCN3CCCC3)C=C2)C2=C(OC(C)(C)[C@@]1([H])C1=CC=CC=C1)C=C(OC)C=C2 |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL301327 |
